Investor relations
Financial calendar
Q3 results
Financial reports
Press releases
Zinzino announces the launch of Singapore as next step in their global expansion
07 April 2022 11:30
OpenZINZINO AB (PUBL): Zinzino acquires brand portfolio with Swiss skincare and supplements
06 April 2022 09:30
OpenZINZINO AB (PUBL): MEMBERS OF THE NOMINATION COMMITTEE FOR ZINZINO AB'S ANNUAL GENERAL MEETING IN 2022
18 November 2021 14:00
OpenZINZINO AB (PUBL): Zinzino announces the launch of South Africa as next step in their global expansion
09 November 2021 11:30
OpenZINZINO AB (PUBL): Zinzino announces launch of Taiwan as next step in the global expansion
09 September 2021 13:00
OpenZINZINO AB (PUBL): Zinzino announces the launch of Malaysia as next step in their global expansion
03 June 2021 11:00
OpenZINZINO AB (PUBL): A new signature BalanceOil from the pioneers of test-based nutrition
15 April 2021 15:00
OpenZINZINO AB (PUBL): Zinzino announces the launch of India as next step in their global expansion strategy
06 April 2021 14:00
OpenThe stock
Sustainability Report
Read more about our sustainability approach, targets and 2021 performance.
Why invest in Zinzino
A clear global strategy with a growth-driven, future-proof business model
Zinzino is one of Europe’s fastest-growing direct sales companies with an aggressive global expansion strategy. The Scandinavian-based health tech company is currently operating in Europe, North America, Asia, Australia, India and Africa. The overall company strategy and business model is to achieve profitable growth in new as well as existing markets. The massive growth momentum of the past decade is expected to stay constant thanks to the stability and structure of the business model in combination with top-of-the-line digital market tools as well as continuous company acquisitions.
Help improve the health of the world
Our product concept is to give health back to the world. Our goal is to get the best out of people with enthusiasm, encouragement and a great deal of energy. We are the most customer-focused direct sales company in the world. Our most important product concept, Balance, is showing continued good growth and we currently have over 500,000 test results based on blood tests in our database. We are the company that has done the most fatty acid analyses in the world.
Product development at the leading edge
Through efficient product development in-house, the company has developed a number of new products in health in which it owns its own important intellectual property rights. The newly developed products are manufactured in our own efficient production facility which means that we have 100% quality control. Zinzino’s strategy in the coming years includes continued product development at the leading edge.
Strong market position and distribution
Zinzino has strong sales organisations in its principal markets with good relationships with its customer base. The broad product portfolio attracts new customer groups and thereby generates growth. Through an updated IT platform and logistics system, Zinzino is well equipped for the expected sales growth in the coming years.
Attractive cash flow enables increased stock dividends and gives a good direct return
Zinzino’s business has a very strong cash-generating capability. Effective management of working capital combined with investments that quickly generate revenue and marginal improvements generate a strong cash flow. Thus, dividends can be distributed in accordance with the target of at least 50 per cent of the free cash flow.
Share this page
Or copy link